The wildly successful Adage Capital hedge fund left one struggling pharma giant for another in the last quarter, according to just-released 13F forms filed with the SEC. We can see that the fund demonstrated a surprisingly bullish sentiment on Teva Pharmaceutical Industries Limited (NYSE:TEVA) while taking profits on Valeant Pharmaceuticals International, Inc. (NYSE:VRX).
Intriguingly, the fund…